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Summary 
We have previously shown that CD4+  T cells from allergic individuals are predisposed to pro- 
duce interleukin (IL)-4 in response  to allergens,  and that allergen  immunotherapy greatly re- 
duced Ib4 production in an allergen-specific fashion. The mechanism that results in the reduc- 
tion of Ib4 synthesis in treated individuals is unknown, but because clinical improvement during 
immunotherapy  is associated with the administration of the highest doses of allergen, we hypothe- 
sized that high concentration of allergen results in the downregulation of IL-4 synthesis in CD4 + 
T cells. In this report, we demonstrated that CD4+  T cells from allergic donors produced high 
levels of IL4 when stimulated with low concentrations of allergen (0.003-0.01/~g/ml), particu- 
larly when B cell-enriched populations presented the antigen. In contrast, the same responding 
CD4 +  T ceU population produced little IL-4 when stimulated with high concentrations of al- 
lergen (10-30/~g/ml), especially when monocytes were used as antigen-presenting calls (APC). 
The quantity of Ib4 produced was also found to be inversely related to the extent of proliferation 
of the CD4+  T ceUs in response to allergen/antigen; maximal proliferation of CD4+  T cells 
occurred in response to high concentrations of antigen when II:4 production was minimal. An- 
tigen presentation by B cell-enriched populations, instead of monocytes, induced less CD4 + 
T cell proliferation, but induced much greater Ib4 synthesis. Moreover, the addition of increasing 
numbers of APC (either B cells or monocytes) to cultures containing a constant number of re- 
sponder T cells resulted in increased T cell proliferation and decreased Ib4 production. These 
results indicate that the circumstances under which memory T cells are activated,  as well as the 
strength of the proliferative signal to T cells, greatly affect the quantity of Ib4 produced. Thus, 
our observations that the cytokine profile of allergen-specific memory CD4+  T cells can indeed 
be modulated by the antigen dose and APC type suggest that methods that preferentially  en- 
hance allergen uptake by monocytes and that enhance T cell proliferation will improve the clin- 
ical efficacy of immunotherapy in the treatment of allergic disease. 
T 
he precise mechanisms by which allergen immunother- 
apy achieves clinical improvement in patients with al- 
lergic rhinitis is poorly understood. Several studies have demon- 
strated that immunotherapy induces a rise in IgG blocking 
antibodies, particularly IgG4 (1, 2),  whereas other studies 
have demonstrated that CD8+  suppressor cells are gener- 
ated during immunotherapy, which can modulate allergen- 
specific IgE production (3). However, these effects are not 
always observed in patients on immunotherapy, which sug- 
gests that other mechanisms are operating. Since natural ex- 
posure to allergen occurs generally by inhalation, whereas 
treatment with immunotherapy involves subcutaneous ad- 
ministration of allergen, it has been postulated that the route 
of antigen exposure may significantly  affect the cytokine 
profiles that develop in antigen/allergen-specific T cells (4). 
In addition, since the amount of allergen administered during 
immunotherapy is much greater than the amount inhaled, 
we and others hypothesized that higher antigen concentra- 
tions would reduce IL-4 synthesis in allergen-specific CD4+ 
T cells, possibly by altering the type of antigen-presenting 
cells or monokines involved (5-8). 
We have previously demonstrated that allergen immuno- 
therapy, which is a clinically effective treatment for patients 
with allergic rhinitis and which involves the subcutaneous 
administration of increasing doses of allergen, greatly reduces 
the production of IL-4 in allergen-specific CD4+  T cells. Al- 
lergen immunotherapy  decreases IL4 production by allergen- 
specific CD4 +  T cells to levels observed with T cells from 
nonallergic subjects, or to levels induced by nonallergenic an- 
tigens, such as tetanus toxoid (9). Inasmuch as the develop- 
ment of allergic disease  with increased IgE synthesis is thought 
to be caused by excessive  production of 1D4 in allergen-specific 
CD4+ T cells (10-15), allergen immunotherapy, by reducing 
IL-4 synthesis and altering the cytokine profiles of allergen- 
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individuals by affecting the underlying regulatory T cells that 
control the disease. 
The purpose of our current study was to investigate a pos- 
sible mechanism by which immunotherapy causes a reduc- 
tion  in  the  quantity  of IL-4 produced by allergen-specific 
CD4 +  T cells. Since clinical improvement during immuno- 
therapy is associated with the administration of the highest 
doses of allergen (16),  we hypothesized that  IL-4 synthesis 
in CD4+  T  cells is downregulated by high concentrations 
of allergen and/or when antigen is presented by monocytes 
rather than by B cells. We, thus, demonstrate that the cytokine 
profile of peripheral blood CD4+  T  cells taken from allergic 
individuals can, in fact, be altered by antigen dose and antigen- 
presenting cell type in vitro,  and we propose that  this is a 
significant mechanism responsible for the success of allergen 
immunotherapy. 
Materials  and Methods 
Donors.  Allergic  donors were characterized by positive  im- 
mediate skin test reactivity to dust mite antigen, Dermatophagoides 
farinae (Def./#  1, and/or to rye grass pollen allergen, Lolium perenne 
(Lol.p.), and by serum IgE levels/>170 IU/ml. Nonallergic subjects 
did not exhibit immediate skin  test reactivity to these allergens 
and had total serum IgE levels <50 IU/ml.  All donors gave in- 
formed consent, and experimental protocols were approved by the 
Stanford University Administrative Panel on Human Subjects in 
Medical  Research. 
Antigens.  Purified Lol./~ group I antigen (National Institute of 
Allergy and Infectious Diseases, Rockville, MD) was used at final 
concentrations ranging from i ng/ml to 50/zg/ml. Partially purified 
house dust mit (Der/~) antigen preparation was generously provided 
by S.  Dreborg (Pharmacia,  Uppsala,  Sweden)  at  105 biological 
equivalent/ml and was used at final concentrations ranging from 
20 ng/ml to 20/~g/ml in culture. Tetanus toxoid (TT) antigen (Con- 
naught Laboratories,  Inc.; Swiftwater, PA) was used in the range 
of 3 ng/ml to 30 #g/ml in culture. 
Isolation of CD4 +  T  Cells.  Peripheral blood T cells were ob- 
tained by rosetting with 2-aminoethylisothiouronium bromide- 
SRBC (17) followed by depletion of SRBC with lysing solution 
(0.155  M  NH4C1,  10 mM KCO3). CD8+  cells were removed 
from the preparation by treatment with anti-OKT8 (anti-CD8) 
mAb followed by the addition of rabbit complement (Pel-Freez 
Biologicals; Rogers, AR), as previously described (18). Cells treated 
in this manner were <6% CD8 positive and >192% CD4 positive. 
Preparation of Antigen-presenting  Cells.  PBMC were depleted of 
T cells by rosetting with aminoethylisothiouronium bromide-treated 
SRBC as described above. The remaining B cells and monocytes 
(E-rosette negative fraction [E-]) were washed three times in PBS, 
treated with mitomycin C  (50/zg/ml; Sigma Chemical Co., St. 
Louis, MO) for 45 rain at 37~  and washed extensively before 
culture. In other experiments, E-negative cells were irradiated (2,500 
tad)  before culture.  To purify monocytes/macrophages, PBMC 
(5-8  x  106/ml) were incubated in 60 mm plastic dishes in com- 
plete medium for 1 h at 37~  Nonadherent cells were removed 
1Abbreviations used in this paper: Deg.l~, Dermatophagoides  farinae; E-, eryth- 
rocyte  rosette-negative;  hr, human recombinant; Lol.p., Lolium perenne; TT, 
tetanus toxoid. 
by gently washing the dishes with warm RPMI 1630 media con- 
taining 5% FCS. The remaining adherent cells were harvested with 
cold PBS, washed three times,  and irradiated at 2,500 tad before 
culture. Monocytes isolated in this manner were typically >99% 
OKMI+  CD14  hi CD33+.  Purified B cells were obtained by re- 
moving monocytes from the E- fraction with two rounds of ad- 
herence to plastic, as described above, and by passage of the cells 
over Sephadex G10 (19). The remaining ceils were then incubated 
with anti-OKM1 (anti-CD1; Ortho Diagnostic Systems, Raritan, 
NJ) mAb for 45 min at 4~  followed by the addition of rabbit 
complement (1:3 [vohvol] Pel-Freez Biologicals), and placed at 37~ 
for 30 rain. After washing three times with RPMI 1630 containing 
5% FCS,  the B lymphocyte-enriched population was incubated 
with 50/~g/ml mitomycin C for 45 rain at 37~  and washed ex- 
tensively before culture. The B lymphocyte-enriched population 
isolated in this manner was typically < 3% OKMI+  and 6-11% 
CD14  l~ CD33 +  (which identify precursors of dendritic ceUs). 
Proliferation Assay.  PBMC were isolated from heparinized blood 
by flotation over Ficoll-Hypaque (Sigma Chemical Co.), as previ- 
ously described (18).  PBMC  (2  x  10S/well) were cultured  in 
triplicate in 96-well plates in media alone (DMEM containing 10% 
AB+ serum [Hazleton Biologics, Inc., Lenexa, KS], vitamins, 1 mM 
sodium pyruvate, 5 #g/ml gentamycin, and 2 mM L-glutamine) 
or with antigen at the appropriate concentration. After 5 d, cul- 
tures were pulsed with [3H]thymidine and harvested  18 h later. 
Incorporation of [3H]thymidine (cpm) was  then determined by 
scintillation counting. Where indicated in the text, proliferation of 
purified CD4+  T cells (1.5  x  10S/well), in response  to antigen, 
was assessed in a similar manner using either irradiated monocytes 
or mitomycin C-treated E-negative cells (5  x  104/well) as APC. 
Cell Cultures.  Purified CD4+  T cells and APC were cultured 
in 24-well plastic dishes (Nunc, Naperville, IL) at 2  x  106 ceUs/ml 
in 10% CO2 with the appropriate antigen: TT, dust mite antigen, 
or rye grass pollen antigen, as previously described (9). After 6 d 
of culture, cells were washed once in PBS and recultured with fresh 
APC,  fresh  antigen,  and 10 U/ml human recombinant (hr)Ib2 
(Amgen Biologicals,  Thousand Oaks, CA). Between days 6 and 
12, cultures were expanded as necessary. At day 12 of culture, cells 
were washed  three times  in  PBS and resuspended  in  complete 
medium at 2  x  106 cells/ml with PHA-P (1:200 [vol:vol]; Difco 
Laboratories  Inc., Detroit, MI) and 1 ng/ml of PMA.  Superna- 
tants were collected after 24 h and kept at  -80~  until they were 
assayed for cytokine content. Where indicated, cells were processed 
for RNA isolation.  In some experiments, antigen specificity of cul- 
tures was confirmed by isolating blast cells at day 6 of culture via 
centrifugation through a discontinuous Percoll gradient at 1,500 
rpm for 45 rain followed by culture of those cells at the 27-45% 
Percoll interface for an additional 6 d of culture. Similar  results 
were obtained using both culture protocols. 
Quantitation of Cytokines.  hlL-2  was measured by biological assay, 
using the murine indicator HT-2 cell line (generously provided by 
Dr. Sam Strober, Stanford), as previously described (18). hlL-4 was 
quantified by ELISA as previously described (10). 
RNA  Isolation and Northern  Blot Analysis.  Analysis of mRNA 
for Ib4 was carried out with RNA extracts from CD4+  T cells 
that had been cultured with various concentrations of allergen and 
mitomycin C-treated E-cells as APC, for 12 d, as described above. 
After a final 8 h stimulation with PHA+PMA, RNA was extracted 
from cells by a rapid isolation  procedure (20),  fractionated on 
formaldehyde-agarose gels, and transferred and cross-linked to nylon 
membranes (Hybond-N; Amersham Corp., Arlington Heights, IL). 
The cDNA probe for IL-4 was a 0.7-kb BamHI digest out of pcD 
3123b vector (21) (generously provided by Dr. Jan de "Cries, DNAX, 
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tide primers (Pharmacia) with o~-32p-dATP (Amersham). Mem- 
branes were hybridized at 42~  for 16 h (overnight) with labded 
cDNA probe in Northern  cocktail containing 50% formamide, 
1 M NaC1, lx PE, 10% dextran sulfate, and 100 gg/ml salmon 
sperm DNA. Blots were washed twice at room temperature for 
15 rain each with 0.2 x SSC/0.1% SDS (lxSSC = 0.15 M NaC1, 
0.17 M sodium citrate) followed by two more washes at 56~  for 
30 rain each with 0.2  x  SSC/0.1% SDS. Blots were exposed at 
- 70~  to XAR film (Eastman  Kodak Co., Rochester, NY). Equal 
loading of RNA was assessed  by ethidium bromide staining of the 
gel. After exposure, blots were stripped with 0.1% SDS at 100~ 
before hybridizing with a second probe. 
Results 
Induction of lG4 Production in CD4+  T  Cells Is Maximal 
at Low Doses of Antigen.  Peripheral  blood CD4+  T  cells 
from allergic donors were cultured with allergen (Lol./x) and 
mitomycin C-treated E-negative ceils (containing B lympho- 
cytes and monocytes) as APC,  and the cytokine profile of 
the responding cells was then determined (10). As depicted 
in Fig.  1 A, maximal IL-4 synthesis by CD4 +  T  cells was 
observed at low concentrations of  allergen (0.01 #g/ml) while 
significantly  less IL-4 synthesis was seen at higher concentra- 
tions of allergen (0.1 and 10 #g/ml). Although greater quan- 
tities of IFN-3~ were produced at higher, as compared to lower, 
concentrations of antigen, the differences were not statisti- 
cally significant (data not shown). Ib2 synthesis varied be- 
tween experiments,  but overall it was not significantly modu- 
lated by antigen concentration. This pattern of I/.,4,  Ib2, 
and IFN-'r synthesis was consistently observed in more than 
ten experiments. 
We next examined whether the dosage of other allergens 
and/or nonallergens was  able  to  modulate CD4+  T  cell 
cytokine synthesis in a similar manner. As seen in Fig.  1 B, 
stimulation of  purified CD4 +  T cells from an allergic donor 
with low and high concentrations of Der./x elicited responses 
similar to those found with high and low concentrations of 
Lol.p. with much enhanced Ib4 synthesis at the lower con- 
centration of allergen. Although the absolute amount of Ib4 
produced varied with each donor, the relative  difference in 
IL4 synthesis at low and high concentrations of allergen was 
consistent in each experiment. In addition, as demonstrated 
in Fig.  1 C, stimulation of CD4+  T  cells isolated from an 
allergic subject with low and high concentrations of TT also 
revealed maximal Ib4 synthesis at low antigen concentra- 
tions. IL-4 production at low antigen concentrations was ob- 
tained only in subjects recently boosted with TT, thus max- 
imizing the number of TT-specific B cells in the responding 
population and suggesting that antigen-specific B calls, rather 
than nonantigen-specific B ceils, were responsible for antigen 
presentation. Comparable results were observed in response 
to  TT  in  a  recently boosted nonallergic donor  (data  not 
shown), demonstrating a consistent effect with all three an- 
tigens tested. 
Since the degree of  proliferation of CD4 +  T cells is affected 
by the antigen concentration, we examined the proliferative 
response  to CD4 +  T  cells from allergic  individuals in the 
first 6 d of culture and determined how it changed as a func- 
tion of allergen concentration. Fig.  2 shows that maximal 
proliferation of the CD4+  T  cells occurred at the highest 
concentrations of allergen (10/zg/ml), and that, at very low 
concentrations of allergen, only minimal T cell proliferation 
was observed.  Similar results were observed when Der.p. or 
TT were used as the antigen (data not shown). Thus, the 
quantity of Ib4 produced by allergen/antigen-spedfic  CD4 + 
T cells, which was maximal with low concentrations of an- 
tigen, was inversely related to the amount of T cell prolifera- 
tion as measured during the first  week of stimulation. 
The reduced production of Ib4 at higher concentrations 
of antigen (Fig.  1) could not be explained by increased con- 
sumption of Ib4 in cultures with increased proliferation,  since 
the supernatants for assay were generated over a short period 
of time (24 h) and since Northern analysis of the T cells for 
Figure I.  IL-4  production  by CD4 + T cells  is enhanced  at low antigen  concentrations.  Purified  CD4 + T cells  were  cultured  with mitomycin  C-treated 
E- cells (B cells and monocytes)  as APC and stimulated  with the indicated  concentrations  of allergen: (A) Lol./x,  (B) Der.p.; or (C) nonallergen, TT. 
Cytokine  production  was assessed  from supernatants  generated  after 12 d of culture (see Materials  and Methods) and is expressed as the mean _  SD 
of triplicate cultures. These results are representative of 10 experiments with allergen and two experiments with TT. 
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Figure 2.  CD4+ T cell proliferation  is maximal at high allergen/antigen 
concentrations.  Purified CD4+  T  cells were cultured  with mitomycin 
C-treated E- cells as APC with the indicated concentrations of allergen. 
After 5 d, the cultures were pulsed with [SH]thymidine  and harvested 18 h 
later. Results are expressed as incorporation of [3H]thymidine (cpm) +  SD 
of triplicate wells. These results are representative of eight experiments. 
I1.-4 transcripts (Fig.  3 A) demonstrated that the quantity 
of mRNA for IL-4 varied directly with the quantity of II.-4 
protein found in supernatants.  In addition, mock experiments 
performed by adding known quantities of IL-4 at the time 
the supematants were generated showed that the T cells gener- 
ated at high versus low antigen concentrations did not use 
II.-4 differentially (Fig.  3 B). 
Antigen Presentation  by B Cell-enriched  Populations  Favors  Ib4 
Synthesis by CD4+  T Cells.  A number of investigators have 
demonstrated that, particularly when low concentrations of 
antigen are present, antigen-specific B cells are 1,000- to 10,000- 
fold more efficient than macrophages in presenting antigen 
to T cells, mainly because 1] cells bind antigen (through Ig 
receptors) much more effectively  than macrophages (22-24). 
Since we observed that at low concentrations of antigen more 
IL-4 was induced, we reasoned that antigen presentation by 
B cells occurred preferentially at low antigen concentrations, 
favoring IL-4 synthesis, while antigen presentation by mono- 
cytes occurred preferentially at high antigen concentrations, 
resulting in decreased IL-4 synthesis. To examine this possi- 
bility, we compared the cytokines induced in CD4 +  T cells 
by irradiated versus mitomycin C-treated E- cells. Inasmuch 
as the E-  population  includes both monocytes, as well as 
radiation-sensitive B cells, and since irradiation eliminates an- 
tigen presentation by B cells, but  not by monocytes (25), 
the irradiated population functionally contained monocytes, 
not  B  cells.  The mitomycin C-treated  E-  population  in- 
duced substantial quantities of II,-4. However, irradiation of 
the E-  cells (2,500  rad) resulted in markedly reduced levels 
of Ib4, a decrease from 16,585 pg/ml to 3,882 pg/ml. Fur- 
thermore, both populations of APC (irradiated and mitomycin 
C-treated E-  cells) induced comparable levels of CD4 +  T 
cell proliferation (data not shown). Therefore, these results 
suggest that maximal IL-4 synthesis by CD4+  T cells occurs 
when B cells, rather than monocytes, present antigen to aller- 
gen-specific T  cells. 
To more directly compare the ability of equal numbers of 
B lymphocytes and monocytes to  induce CD4 +  IL-4 syn- 
thesis,  E-  cells from an allergic donor were separated into 
Figure 3.  Decreased  I1:4 synthesis at high antigen concentrations  is 
not due to enhanced uptake. (A): I1:4 mRNA expression correlates with 
quantity of I1:4 protein in supernatants. Purified CD4+ T cells were cul- 
tured with mitomycin C-treated E- cells as APC (as described in Fig. 
1) with Lol.p.,  0.001/xg/ml (lane I ),  or 10/xg/ml (lane 2). At day 12, 
cells  were stimulated with mitogen for 6 h and RNA isolated for Northern 
blot analysis  using a cDNA probe specific for human II:4. Ethidium bro- 
mide staining of 18S and 28S RNA is presented as a demonstration  of 
equal loading of KNA. The exposure time was 3 d. Levels  of I1:4 protein 
in supernatants of parallel  cultures were 25,387 pg/ml at 0.001/~g/ml Lol./~ 
and 3,410 pg/ml at 10/zg/ml Lol./~ (B): Differences in 1I:4 production 
at high and low antigen concentrations  are not due to differential Ib4 
uptake. Purified CD4+ T cells were cultured with mitomycin C-treated 
B lymphocyte-enriched cells as APC, as described in Fig. 1, with the indi- 
cated concentrations  of TT. At day 12, cells were washed, resuspended 
at 2  x  106 cells/ml, and restimulated with PHA  +  PMA. In some cul- 
tures, IL-4 (10,000 pg) was added at the time of restimulation  to deter- 
mine if the restimulated T cells differentially  used I1:4. I1:4 levels,  without 
the addition of I1:4, was, for 0.005/xg/ml Tq2 5,020 pg/ml, and for 5 
/xg/ml TT; 2,111 pg/ml indicating that 9,280 and 8,530 pg/ml, respec- 
tively, of the added 11:4 remained in the cultures. A control well con- 
taining 10,000 pg/ml I1:4 in the absence of cells was assayed as containing 
10,800 pg/ml after 24-h culture. 
populations of B lymphocytes and monocytes. Fig.  4 shows 
that a cell population highly enriched with B lymphocytes 
induced significantly more IL-4 in CD4 +  T  cells than did 
an equal number of monocytes at both low and high concen- 
trations of allergen. The monocytes induced less II.-4 than 
did the B cell-enriched population, whether the monocytes 
were treated with mitomycin C or with irradiation (data not 
shown). In most experiments, monocytes induced more IFN-y 
production by CD4 +  T cells than did the B cell population 
(data not shown). Thus, antigen presentation by B lympho- 
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Figure  4.  Purified B cells as APC are more effective than monocytes 
at inducing II--4 synthesis in CD4+  T  cells. Purified CD4+  T  cells were 
cultured with mitomycin C-treated B cells or monocytes, as described in 
Fig. 1, with the indicated concentrations of allergen. Cytokine levels were 
determined as in Fig. 1 and are expressed as the mean  _+ SD of triplicate 
cultures.  These results are representative of five experiments. 
cyte-enriched populations was superior to that of monocytes 
for the induction of Ib4 synthesis in memory CD4 +  T cells. 
Increasing the APC: CD4+  T  Cell Ratio Inhibits 11_,4 Syn- 
thesis.  Inasmuch as enhanced IL-4 synthesis was observed 
at lower concentrations of antigen, even when using mono- 
cytes as APC,  we asked if the number of APC in culture 
and, consequently, the strength of the signal delivered to the 
CD4 +  T cell also affected lymphokine synthesis. Therefore, 
we examined the effect of increasing the ratio of APC to 
CD4+  T cells in culture on Ib4 synthesis. As demonstrated 
in Fig. 5 A, increasing the number of APC in culture while 
keeping the number of responder T  cells constant resulted 
in decreased II.,4 synthesis using both types of APC, although 
the B cell-enriched population was far better than mono- 
cytes in inducing Ib4  synthesis at all APC concentrations 
tested. Moreover, decreased IL-4 synthesis at higher concen- 
trations  of APC  correlated with  increased CD4+  T  cell 
proliferation (Fig. 5 B), although monocytes induced greater 
CD4+  T cell proliferation at both concentrations of APC. 
Fig.  6 shows that, with both types of APC, CD4+  T  cell 
proliferation was also enhanced with increasing concentra- 
tions of allergen, with monocytes inducing greater prolifera- 
tion,  particularly at higher antigen concentrations. These 
results again indicate that the quantity of IL-4 produced by 
T cells is inversely related to the amount of T cell prolifera- 
tion, that stronger signaling from APC (with increased an- 
tigen or increased APC number) is associated with reduced 
IL-4 synthesis, and that B cells are superior to monocytes at 
inducing Ib4  synthesis in memory CD4+  T  cells. 
CD4+  Lymphokine  Synthesis  Is Determined  by the APC 
Present at the Primary Stimulation.  Since induction of max- 
imal l'b4 synthesis in our in vitro cultures required two stimu- 
lations with antigen and APC, we asked whether the pres- 
ence of B lymphocyte-enriched cells as the APC type was 
required for both the first and second stimulations. CD4 + 
T lymphocytes were cultured with allergen and either B lym- 
phocyte-enriched cells or monocytes for 6 d, at which time 
cells were restimulated with allergen, hrlL-2, and either the 
original or the other APC type for the second stimulation. 
As depicted in Fig. 7, maximal CD4 +  Ib4 synthesis occurred 
using B lymphocyte-enriched cells as APC during the first 
stimulation, whether or not the B cell population was used 
during the second stimulation. In contrast, use of monocytes 
as APC for the first stimulation resulted in the induction of 
low levels of IL-4. Thus, maximal IL-4 synthesis by CD4 + 
memory T  lymphocytes occurred when a B lymphocyte- 
enriched population was used as APC during the first stimu- 
lation, indicating that circumstances with which the resting 
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Figure  5.  Increasing the APC:  CD4+  T  cell ratio inhibits IL-4 synthesis, yet enhances CD4+  T  cell proliferation.  A  fixed number of purified 
CD4+  T  cells (1.5  x  106/ml) were cultured with either mitomycin C-treated B cells (open circles) or monocytes (closed triangles) at the indicated con- 
centrations with 0.001/zg/ml Lol./x Cytokine levels were determined, as described in Fig.  1, and are expressed as the mean  _+  SD of triplicate cultures 
(A). CD4+  T  cell proliferation was determined as described in Fig. 2, and results are expressed as incorporation of [3H]thymidine  _+  SD of triplicate 
wells  (B).  These results are representative of three experiments. 
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Figure 6.  Both  monocytes  and purified  B cells  induce  augmented  CD4 + 
T cell proliferation  with  increasing  concentrations  of allergen. Prolifera- 
tive response of CD4+ T cells (1.5 x 106/ml) to various  concentrations 
of allergen presented by mitomycin  C-treated B cells (open  circles; 5  x 
105/ml) or monocytes  (closed triangles;  5 x 105/ml). Results  are expressed 
as the incorporation  of [3H]thymidine -+  SD of triplicate cultures over 
the last 18 h of a six day culture  period. These results are representative 
of four experiments. A, monocytes;  O, B cells. 
memory T  cell was activated determined whether I1:4 was 
produced, and that manipulation of the cytokine profile of 
activated memory T cells at the time of the second stimula- 
tion was not possible. 
Discussion 
In the current report, we demonstrated,  using human memory 
CD4 +  T  cells, that cytokine production can be modulated 
by the antigen dose and APC type and proposed that allergen 
immunotherapy operates through such mechanisms. Stimu- 
lation of CD4+  T  cells from allergic individuals with low 
concentrations of allergen or antigen (1-100 ng/ml) in vitro, 
which  enhances  antigen  presentation  by B  cells  (22-24), 
resulted in enhanced I1:4 synthesis,  whereas stimulation of 
the same CD4 +  T cell population with high concentrations 
of allergen or antigen (10-30 gg/ml) resulted in minimal I1: 
4  synthesis.  Moreover,  we  demonstrated that  B  lympho- 
cyte--enriched  populations were more effective than mono- 
cytes at inducing I1:4  synthesis in allergen-specific  CD4+ 
T cells and that the quantity of I1:4 produced was inversely 
related to the extent of proliferation of the CD4+  T  ceils. 
It is possible  that, at low antigen concentrations, contami- 
nating Fc~RI +  dendritic cells, expressing antigen-specific IgE, 
presented antigen instead of B cells and induced high levels 
of I1:4 (26). However, this is unlikely since irradiation, which 
does not affect antigen presentation by dendritic cells (27) 
but eliminates antigen presentation by B cells, greatly reduced 
the capacity of the B cell-enriched population to induce I1:4 
production. 
Previous studies examining the regulation of cytokine syn- 
thesis  in CD4+  T  cells  have demonstrated that cytokine 
production in naive CD4+ T cells is relatively easy to manipu- 
late by controlling the presence of I1:4,  or by the addition 
of anti-Ib4 mAb or anti-IFN-3' mAb to the microenviron- 
ment of the responding T cells (28, 29). However, the cytokine 
profiles  of memory CD4 +  T  cells in established  immune 
responses have been more difficult to manipulate, and attempts 
to alter the cytokine profile of CD4 +  T cells with cytokines 
or anticytokine  mAb have been largely unsuccessful (30-32). 
Although the presence of Ib12 can enhance IFN-'y synthesis, 
a recent report has demonstrated that ID12 does not reduce 
I1:4 synthesis in human CD4+  memory T cells (33). How- 
ever, we have previously shown that allergen immunotherapy 
can significantly reduce the quantity of IL-4 produced by 
allergen-specific CD4+  T  cells (9),  and our current results 
indicate that immunotherapy  may control the cytokine  profiles 
of allergen-specific memory CD4+  T  cells by affecting the 
antigen concentration and the APC type. 
The idea that antigen presentation by B cells enhances IL-4 
Figure 7.  CD4+ T cell lymphokine  synthesis is 
determined  by the APC present at the initial  stimula- 
tion in vitro. Purified  CD4+ T cells were cultured 
with 50 gg/ml Lo/./~  and either mitomycin  C-treated 
B cells or irradiated macrophages for 6 d, at which 
time  cells  were  restimulated  with allergen,  rhlL-2, and 
either the original  or a different  APC for the second 
stimulation.  At day 12, cytokine  levels  were  determined 
and are expressed as the mean _+ SD of triplicate cul- 
tures. These results are representative of three ex- 
periments. 
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extensively in the past.  Our results demonstrating that IL-4 
synthesis is enhanced in human memory CD4+ T cells when 
antigen is presented by B lymphocyte-enriched  cells are similar 
to those results with murine CD4+  T  cells in which we 
demonstrated that KLH-primed routine CD4+  T cells syn- 
thesized more IL-4 and less IFN-3, in vitro when B lympho- 
cytes, and not macrophages, presented antigen at low con- 
centrations (10 ng/ml). However, in that study the quantity 
of IL-4 induced by both B cells and macrophages was equiva- 
lent at higher concentrations of antigen (1 #g/ml) (5). An- 
tigen presentation by B cells has also been shown to prefer- 
entially stimulate established Th2 rather than Thl clones (34), 
but since T cell clones have stable cytokine profiles, the type 
of APC used did not affect the cytokine profile  of the re- 
sponding T cell. In contrast, because resting memory CD4 + 
T cells must differentiate upon stimulation with antigen be- 
fore secreting IL-4 (5, 10), we believe that, in our experimental 
system, antigen presentation by B lymphocytes actually modu- 
lated the cytokine profile of the responding T cells and did 
not simply select out T cells already committed to produce 
high levels of ILo4. However, once the resting memory CD4+ 
T  cells were activated in vitro by a specific APC type, the 
cytokine profile of the activated T cell became relatively fixed 
and resistant  to subsequent change (Fig. 7). Future studies, 
though, that examine memory T cells at the single cell level 
will be required to directly demonstrate the plasticity in the 
cytokine profiles of individual resting memory CD4+ T cells. 
Since B cells are extremely efficient at presenting antigen 
when the antigen concentration is low (22, 23), our studies 
showing that antigen presentation by B lymphocyte-enriched 
cells preferentially  induce IL-4 are consistent with previous 
in vivo and in vitro observations that IgE synthesis (and, there- 
fore, IL-4 synthesis) is optimal at low antigen doses (35, 36). 
We demonstrated that the induction of substantial  quanti- 
ties of IL-4 in T cells by B lymphocyte-enriched cells, partic- 
ularly at low antigen concentrations, occurred with minimal 
CD4+ T cell proliferation. In contrast, induction by mono- 
cytes of high levels of IFN-3' synthesis and low levels of IL-4 
synthesis was associated with vigorous T cell proliferation, 
particularly at high concentrations of antigen. These obser- 
vations suggest that the induction of Th2 cytokines in human 
CD4+  T cells does not require substantial  T cell prolifera- 
tion, whereas the induction of Thl cytokines requires active 
proliferation. 
The dissociation of T cell proliferation and IL-4 produc- 
tion has been observed in the past in several murine systems. 
First, Evavold et al., using hemoglobin-specific  murine T cell 
clones,  showed that alteration of the amino acid sequence 
of the relevant hemoglobin peptide, which causes a reduc- 
tion in its affinity for the hemoglobin-specific T cell receptor, 
results in decreased T cell proliferation, but not in decreased 
IL-4 production, by the clone (37). That IL-4 secretion does 
not require significant  T cell proliferation is also supported 
by studies with the antigen collagen type IV whose peptides 
have low affinity for non-H-2  s MHC molecules and induce 
poor CD4 +  T cell proliferation, yet substantial II,-4 produc- 
tion in non-H-2  s mice. In contrast, the same peptides bind 
effectively to H-2  s MHC molecules and induce vigorous T 
cell proliferation with the production of IL-2 and IFN-3' in 
H-2  s mice (38). Finally, studies by Gajewski et al. show that 
the development of Th2, but not Thl cells, from Th0 cells 
is enhanced by the relative lack of costimulatory signaling 
from APC (39). Although their study suggests that IL-4 syn- 
thesis correlates with the induction of anergy in T cells, our 
studies indicate that IL-4 synthesis can occur without the de- 
velopment of anergy in the T cells, since our IL-4-producing 
cells could proliferate  when restimulated with antigen and 
APC (data not shown). 
Taken together, these results  suggest that the induction 
of IL-4 synthesis involves T  cell signaling mechanisms that 
are distinct from those required for IL-2 and IFN-3, synthesis, 
and that stronger T cell activation signals in memory CD4+ 
T cells (i.e., with greater TCR cross-linkage, higher antigen 
concentration, or higher avidity of antigen peptide for MHC 
class II or TCR) induce greater T cell proliferation and less 
Th2 cytokines. These differences  in signaling may subsequently 
result in the development of effector CD4 +  T cells with al- 
ternate activation pathways;  one using signaling by the hy- 
drolysis of phosphatidylinositol biphosphate and activation 
of protein kinase C  (Thl pathway), and the other relying 
on a phosphatidylinositol biphosphate- and protein kinase 
C-independent pathway (Th2 pathway) (40, 41). In addition, 
it is possible that very potent signaling to T cells (with ultra 
high levels of antigen or antigen peptide, for example) results 
in T cell anergy or apoptosis (42, 43), perhaps analogous to 
the situation observed in thymic differentiation during which 
high concentrations of antigen result in negative selection 
(44). In the peripheral lymphoid organs in vivo, very high 
concentrations of antigen may also eliminate T cells bearing 
high affinity receptors for antigen but leave T cells bearing 
low affinity receptors.  On subsequent exposure to antigen, 
such T cells may proliferate poorly to antigen and produce 
Th2 cytokines as is seen in mice after treatment with very 
high concentrations of an aqueous protein antigen (45). Al- 
ternatively, the cytokine profiles of T cells may be controlled 
by APC-secreted cytokines, such as IL-12, which greatly en- 
hances IFN-3, synthesis (33, 46, 47), or IL-IO, which inhibits 
IFN-3' production in T cells (48). In our cultures, however, 
IL-12 and IL-10 had only minimal effects  on the cytokine profiles 
ofCD4+ T cells, since the addition of a neutralizing anti-IL-12 
mAb did not affect cytokine synthesis and since the addition 
of a neutralizing anti-IU10 mAb decreased IL-4 synthesis only 
slightly (data  not shown). 
In summary, our results demonstrate a mechanism by which 
allergen immunotherapy reduces IL-4 synthesis in allergen- 
specific memory CD4+  T cells. We showed that the quan- 
tity of IL-4 produced by CD4+  T cells can be modified by 
antigen concentration and APC type. These results suggest 
that modifications of immunotherapeutic methods that en- 
hance allergen uptake and presentation by monocytes and that 
enhance allergen-specific T cell proliferation will greatly im- 
prove the clinical efficacy  of immunotherapy in the treatment 
of allergic disease. Finally, our observations suggest that im- 
1087  Secrist  et al. munotherapy, with high antigen doses that induce vigorous 
T  cell proliferation,  may be applicable to other diseases in 
which the production of inappropriately high levels of I/.-4 
in memory CD4 +  T cells requires reduction in an antigen- 
specific  manner  (e.g.,  lepromatous  leprosy  and  other  in- 
fections). 
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